Valuation: Net Medical Xpress Solutions, Inc.

Market Cap 1.07M 968K 894K 808K 1.53M 101M 1.57M 10.71M 4.27M 53.93M 4.03M 3.94M 172M P/E 2015
32.9x
P/E 2016 -5.75x
Enterprise Value 827K 745K 688K 622K 1.18M 77.53M 1.21M 8.25M 3.29M 41.52M 3.1M 3.04M 132M EV / Sales 2015
1.04x
EV / Sales 2016 0.65x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
1 day-28.67%
Current month-28.67%
1 month-28.67%
3 months-28.67%
6 months-28.57%
Current year+66.67%
1 month 0
Extreme 0.0005
0
Current year 0
Extreme 0.0004
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 1.0E-6
0.02
5 years 0
Extreme 1.0E-6
0.75
10 years 0
Extreme 0
0.75
Manager TitleAgeSince
President - 25/06/2019
Director TitleAgeSince
Director/Board Member 64 31/12/2002
Director/Board Member 84 31/12/2004
Director/Board Member - 28/02/2018
Change 5-day change 1-year change 3-year change Capi.($)
-28.67%0.00%+400.00%-96.69% 18.83K
-2.26%-6.24%+2.45%+40.97% 3,870B
+2.12%+0.41%-9.72%+776.46% 415B
+8.82%+3.76%-45.64%+13.54% 400B
+2.48%-3.90%+53.24%+163.87% 273B
+0.25%-2.27%-3.46%+55.70% 270B
+1.46%-4.95%+64.58%+366.73% 235B
+2.34%+48.95%-31.96%+824.34% 134B
+3.16%-5.56%-40.30%-19.06% 107B
+3.67%-1.00%+53.12%+152.07% 94.12B
Average -4.08%+2.74%+44.23%+227.79% 580B
Weighted average by Cap. -0.55%-3.36%+2.13%+130.26%

Financials

2015 2016
Net sales 4.22M 3.81M 3.52M 3.18M 6.01M 396M 6.16M 42.13M 16.79M 212M 15.85M 15.51M 675M 3.04M 2.74M 2.54M 2.29M 4.34M 286M 4.44M 30.39M 12.11M 153M 11.43M 11.18M 487M
Net income 151K 136K 126K 114K 215K 14.16M 220K 1.51M 601K 7.58M 567K 555K 24.14M -344K -310K -286K -259K -490K -32.26M -502K -3.43M -1.37M -17.28M -1.29M -1.26M -54.99M
Net Debt -340K -306K -283K -256K -484K -31.89M -496K -3.39M -1.35M -17.08M -1.28M -1.25M -54.35M -247K -223K -206K -186K -352K -23.17M -360K -2.46M -982K -12.41M -927K -907K -39.48M
Logo Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Employees
23
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. NMXS Stock